Related Experiment Video
Updated: Sep 7, 2025

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
Published on: May 3, 2024
Poroptosis: A form of cell death depending on plasma membrane nanopores formation
Hao Li1,2, Zihao Wang1,2, Xiaocui Fang3,2
1Protein & Peptide Pharmaceutical Laboratory, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, P. R. China.
Abstract:
Immunogenic cell death (ICD) in malignant cells can decrease tumor burden and activate antitumor immune response to obtain lasting antitumor immunity, leading to the elimination of distant metastases and prevention of recurrence. Here, we reveal that ppM1 peptide is capable of forming irreparable transmembrane pores on tumor cell membrane, leading to ICD which we name poroptosis. Poroptosis is directly dependent on cell membrane nanopores regardless of the upstream signaling of cell death. ppM1-induced poroptosis was characterized by the sustained release of intracellular LDH. This unique feature is distinct from other well-characterized types of acute necrosis induced by freezing-thawing (F/T) and detergents, which leads to the burst release of intracellular LDH. Our results suggested that steady transmembrane-nanopore-mediated subacute cell death played a vital role in subsequent activated immunity that transforms to an antitumor immune microenvironment. Selectively generating poroptosis in cancer cell could be a promise strategy for cancer therapy.
Insights
A novel cell death pathway, poroptosis, is induced by the ppM1 peptide through transmembrane pores. This sustained cell death activates antitumor immunity, offering a promising cancer therapy strategy.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Immunogenic cell death (ICD) reduces tumor burden and enhances antitumor immunity.
- Effective ICD strategies are crucial for preventing cancer recurrence and metastasis.
Purpose of the Study:
- To investigate the mechanism of ppM1 peptide-induced cell death.
- To characterize this novel form of ICD and its therapeutic potential.
Main Methods:
- Treatment of tumor cells with ppM1 peptide.
- Analysis of cell membrane integrity and cell death markers.
- Assessment of immune response activation.
Main Results:
- ppM1 peptide induces irreparable transmembrane pores, causing a novel ICD termed poroptosis.
- Poroptosis is characterized by sustained, not burst, release of LDH.
- This sustained cell death promotes an antitumor immune microenvironment.
Conclusions:
- Poroptosis is a distinct ICD mechanism dependent on cell membrane nanopores.
- ppM1-induced poroptosis shows potential as a cancer therapy strategy.
- Targeting poroptosis may enhance antitumor immunity and combat cancer progression.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Cell Motility through Blebbing
Blebbing Through the Matrix
In multicellular...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Apoptosis

